Open sidebar
Focus
csl
Australia News
|
Monica O’Shea
CSL Delivers $2.9 Billion Profit, 110 Million Flu Vaccine Doses
CSL said developing new and better vaccines is a strategic priority for the company going forward.
Aug 13, 2024
|
Monica O’Shea
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Aug 13
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia News
|
Celene Ignacio
Groundbreaking Asthma Drug Could Revolutionize Treatment
Sep 12, 2023
|
Celene Ignacio
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Sep 12
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Vaccines & Safety
|
Jessie Zhang
Australia Inks Next-Gen mRNA Technology Deal With US
Nov 02, 2022
|
Jessie Zhang
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Nov 02
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia News
|
Marina Zhang
Australian University to Collaborate with Moderna for mRNA Vaccine Research
Mar 10, 2022
|
Marina Zhang
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Mar 10
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia News
|
Marina Zhang
Australia Approves First Cell-Based Flu Vaccines For Kids Aged Two and Older
Mar 08, 2022
|
Marina Zhang
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Mar 08
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email